GNVR
Genvor IncPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- X Sep 30 Short interest jumps 762.5% to 1.7K
Signal stack
Where each data set points today.
- InsidersNO TRADES
No open-market buys or sells in 12 months. Recent filings are awards, exercises and tax withholding.
- TrendUPTREND
8% above its 50-day average.
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Apr 15, 2026 | Pawlak Chad Lee Sr. Chief Executive Officer | AWARD | $125.0K |
| Apr 7, 2026 | Pawlak Chad Lee Sr. Chief Executive Officer | AWARD | 250,000 sh |
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026SecBot reports
4 filings · 0 bullish · 0 bearish · 4 neutral- NEUTRAL 8-KOct 26, 2026
Genvor entered into an Intellectual Property Assignment Agreement with founder and CSO Dr. Jesse Jaynes, confirming the company's ownership of its peptide library (approximately 9,000 antimicrobial peptides), the BioCypher AI platform, and all related data. The agreement clarifies IP ownership…
🔒 Fresh report (last 24h), subscribers only
- NEUTRAL 8-KOct 19, 2026
Genvor Inc. issued two short-term promissory notes totaling $30,000 in proceeds to board members…
Monitor the upcoming maturity date (April 8, 2027) for repayment risk. The small size and insider nature of these notes suggest routine cash management rather than a distress signal, but the junior…
- NEUTRAL 8-KJun 22, 2026
{ "summary": "Genvor Inc. issued a warrant to purchase 300,000 shares to Evergreen Capital…
LLM returned non-JSON response. Review the filing manually.
- NEUTRAL 8-KApr 22, 2026
Genvor Inc. entered into a securities purchase agreement with Evergreen Capital Management LLC to…
Monitor the funding of subsequent tranches, which are contingent on the company filing an S-1 registration statement and receiving SEC comments. The convertible note's terms, including the 10%…
All GNVR filing & press-release reports (4)
- 8-K reportOct 26, 2026
- 8-K reportOct 19, 2026
- 8-K reportJun 22, 2026
- 8-K reportApr 22, 2026